EICOSANOIDS AND PULMONARY VASCULAR TONE
EICOSANOIDS AND PULMONARY VASCULAR TONE
批准号:
6490580
负责人:
SANDRA L PFISTER
金额:
$10.77万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2003-12-31
中文摘要
说明(申请人摘要):近年来,
血管内皮细胞合成和释放多种因子
这对调节血管张力的作用已经变得明显。在……里面
肺血管,这些调查人员发现了一种
内皮依赖性收缩因子作为血管收缩因子的血栓素
A2.在许多情况下,增加对
血栓素A2与肺部疾病有关,包括肺部疾病
高血压和猝死。因此,该计划的长期目标是
建议的研究是调查花生四烯酸是
由肺血管代谢为血栓素A2和
血栓素A2是参与血管紧张素转换酶调节的重要介质
正常和病理生理状态下的肺血管张力。
具体地说,已知花生四烯酸和乙酰甲胆碱诱导
肺动脉收缩由血栓素A2和血栓素介导
去除内皮层可以消除收缩。然而,
从肺动脉分离的内皮细胞不能合成
血栓素A2。由特定目标1描述的实验将调查
肺血管合成血栓素A2的假说
内皮细胞和贴壁细胞之间的相互作用。可能的
候选的贴壁细胞包括血小板、中性粒细胞
白细胞或单核细胞。研究表明,血栓素A2诱导
血小板聚集和血管平滑肌收缩是介导的
通过激活一个膜结合的受体。研究这些问题的一个局限
血栓素A2在肺部疾病中的作用是不能
辨证血小板与血管通畅的作用
肌肉受体对观察到的血流动力学反应,因为可用
不幸的是,血栓素受体拮抗剂是非选择性和阻滞性的。
包括血小板和血管受体。调查人员已经确定
一组缺乏血管但不缺乏血小板的兔子,
血栓素A2受体。由特定目标2描述的实验将使用
以研究血栓素A2及其受体的假说
血管受体在肺血管调节中的重要作用
语气。具体来说,他们将调查年龄和性别的影响
血管对血栓素激动剂和血栓素A2反应性的研究
受体密度,表征受体数量和受体密度的差异
应答者和应答者培养血管细胞的功能反应
无反应的肺动脉和评估血管的作用
血栓素A2受体在肺栓塞模型中的作用。
英文摘要
DESCRIPTION (Applicant's abstract): In recent years, the importance of
various factors synthesized and released from the blood vessel endothelium
that contribute to the regulation of vascular tone has become apparent. In
pulmonary vessels, these investigators have identified an
endothelium-dependent contracting factor as the vasoconstrictor thromboxane
A2. There are a number of incidences where an increased synthesis of
thromboxane A2 is associated with pulmonary disease, including pulmonary
hypertension and sudden death. Therefore, the long term objective of the
proposed studies is to investigate the hypothesis that arachidonic acid is
metabolized by pulmonary blood vessels to thromboxane A2 and that
thromboxane A2 is an important mediator involved in the regulation of
pulmonary vascular tone under both normal and pathophysiological states.
Specifically, it is known that arachidonic acid and methacholine-induced
contractions of pulmonary arteries are mediated by thromboxane A2 and
removal of the endothelial layer abolishes the contractions. Yet,
endothelial cells isolated from pulmonary arteries do not synthesize
thromboxane A2. Experiments described by specific aim 1 will investigate
the hypothesis that thromboxane A2 synthesis in pulmonary vessels requires
the interaction between the endothelial cells and adherent cells. Possible
candidates for the adherent cells include platelets, polymorphonuclear
leukocytes or monocytes. Studies have shown that thromboxane A2-induced
platelet aggregation and vascular smooth muscle vasoconstriction is mediated
via activation of a membrane-bound receptor. One limitation to studying the
role of thromboxane A2 in pulmonary disease is the inability to
differentiate the contribution of the platelet and the vascular smooth
muscle receptor to the observed hemodynamic responses because the available
thromboxane receptor antagonists are unfortunately non-selective and block
both the platelet and vascular receptors. The investigators have identified
a subset of rabbits that are deficient in vascular, but not platelet,
thromboxane A2 receptors. Experiments described by specific aim 2 will use
these rabbits to investigate the hypothesis that thromboxane A2 and its
vascular receptor are important to the regulation of pulmonary vascular
tone. Specifically, they will investigate the influence of age and gender
on the vascular responsiveness to thromboxane agonist and thromboxane A2
receptor density, characterize the differences in receptor number and
functional responses in vascular cells cultured from responder and
nonresponder pulmonary arteries and assess the role of the vascular
thromboxane A2 receptor in a model of pulmonary embolism.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.prostaglandins.2008.08.002
发表时间:
2008
期刊:
Prostaglandins & other lipid mediators
影响因子:
2.9
作者:
[Pfister,SandraL]
通讯作者:
Pfister,SandraL
Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits.
主动脉血栓素受体缺乏会改变胆固醇喂养兔子的血管反应性。
DOI:
10.1016/j.atherosclerosis.2006.02.004
发表时间:
2006
期刊:
Atherosclerosis
影响因子:
5.3
作者:
[Pfister,SandraL]
通讯作者:
Pfister,SandraL
Role of 15-lipoxygenase in Enhanced Pulmonary Vasoconstriction in Females
-
批准号:7738175
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2009
-
负责人:SANDRA L PFISTER
-
依托单位:
Role of 15-lipoxygenase in Enhanced Pulmonary Vasoconstriction in Females
-
批准号:7924694
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2009
-
负责人:SANDRA L PFISTER
-
依托单位:
EICOSANOIDS AND PULMONARY VASCULAR TONE
-
批准号:6343576
-
项目类别:
-
资助金额:$10.46万
-
财政年份:1998
-
负责人:SANDRA L PFISTER
-
依托单位:
EICOSANOIDS AND PULMONARY VASCULAR TONE
-
批准号:6139233
-
项目类别:
-
资助金额:$10.16万
-
财政年份:1998
-
负责人:SANDRA L PFISTER
-
依托单位:
EICOSANOIDS AND PULMONARY VASCULAR TONE
-
批准号:2857918
-
项目类别:
-
资助金额:$10.66万
-
财政年份:1998
-
负责人:SANDRA L PFISTER
-
依托单位:
EICOSANOIDS AND PULMONARY VASCULAR TONE
-
批准号:2472602
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1998
-
负责人:SANDRA L PFISTER
-
依托单位:
海外基金